Mitch Goldman is a physician-scientist serving as the SVP and Head of Research and Development for Global Rare Diseases at Chiesi Group. With extensive experience in the pharmaceutical industry, he specializes in translational medicine, biomarker development, and leading cross-functional teams from early development to medical affairs. He earned his MD and PhD from Case Western Reserve University.
He has a deep expertise in developing therapies for rare conditions, including pulmonary, rheumatology, and autoimmune diseases. He has overseen the development of small molecules, biologics, and gene therapies, navigating multiple health authorities. He has contributed to over 40 publications in prestigious peer-reviewed journals.
He is focused on advancing scientific understanding and incorporating patient experiences into developing holistic solutions for the rare disease community.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Explore more public profiles from related professionals.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.